Oncolytic virus therapy

Details for Australian Patent Application No. 2002256510 (hide)

Owner Wellstat Biologics Corporation

Inventors MILLER, Jeffrey A.; Groene, William S.; Mueller, Stephen N.

Agent Blake Dawson Waldron Patent Services

Pub. Number AU-B-2002256510

PCT Pub. Number WO2002/091997

Priority 60/290,051 11.05.01 US

Filing date 9 May 2002

Wipo publication date 25 November 2002

Acceptance publication date 30 August 2007

International Classifications

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 May 2003 Application Open to Public Inspection

  Published as AU-B-2002256510

4 December 2003 Change of Name(s) of Applicant(s), Section 104

  Pro-Virus, Inc. The name of the applicant has been changed to Wellstat Biologics Corporation

30 August 2007 Application Accepted

  Published as AU-B-2002256510

3 January 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002256511-DELIVERY SYSTEM AND METHOD FOR UNIFORM DISPLAY OF SUPPLEMENTAL CONTENT

2002256509-UTILIZATION OF AN INFRARED PROBE TO DISCRIMINATE BETWEEN MATERIALS